大日住薬（4506）　Sunovion Pharmaceuticals Inc. Announces Initiation of Phase 3 Clinical Trial Program for SUN-101/eFlow (Glycopyrrolate) in Moderate-to-Very Severe Ch 2015/02/26
/-
読み込み中…